Prescribing quality improvement: reducing high-dose antipsychotic use

Prajapati, Asta R., Johnston, Esther, Ugochukwu, Uju and Solomka, Bohdan (2017) Prescribing quality improvement: reducing high-dose antipsychotic use. Progress in Neurology and Psychiatry, 21 (3). pp. 18-21. ISSN 1367-7543

[thumbnail of Accepted_Manuscript]
PDF (Accepted_Manuscript) - Accepted Version
Download (631kB) | Preview


Evidence of efficacy for high‐dose antipsychotic therapy (HDAT) and antipsychotic combinations (AC) is lacking, while evidence of harm is compelling. Significantly higher proportions of Norfolk and Suffolk NHS Foundation Trust (NSFT) patients were being prescribed HDAT and AC compared with the national averages. Here, the authors describe a quality improvement program to rationalise and reduce HDAT and AC prescribing in NSFT, to bring it in line with, or below, the national average. The initiative demonstrates that prescribing culture can be improved through a sustained multi‐professional team approach involving education and training, a targeted campaign, a proactive clinical pharmacy team and pharmacists' support.

Item Type: Article
Faculty \ School: Faculty of Science > School of Pharmacy
Depositing User: LivePure Connector
Date Deposited: 26 Sep 2019 12:30
Last Modified: 22 Oct 2022 05:08
DOI: 10.1002/pnp.475

Actions (login required)

View Item View Item